Manoj Gottipati, Ph.D.

Manoj Gottipati, Ph.D. has a wealth of experience in the field of research. Manoj began their career in 2006 as an Undergraduate Research Assistant at the Indian Institute of Technology, Kharagpur. In 2008, they worked as an Intern at Dr. Reddy's Laboratories. In 2009, they were an Intern at the Friedrich Miescher Laboratory of the Max Planck Society, where they trained an inhouse software QPalma, a tool for short read alignment which takes splice sites into consideration, using the genomic and transcriptomic information of Caenorhabditis elegans. Manoj also quantified the alternative RNA transcripts of Caenorhabditis elegans using quantitative PCR and capillary electrophoresis. In 2010, they became a Postdoctoral Research Associate and Graduate Research Assistant at The University of Alabama at Birmingham, where they studied the morpho-functional changes in primary astrocytes treated with water-soluble single-walled carbon nanotubes to highlight their potential use as drug delivery vehicles. Manoj also used novel genetic sensors to study the mechanism of action of water-soluble single-walled carbon nanotubes on cultured astrocytes and evaluated the effects of single-walled carbon nanotube films on the properties of astrocytes to find a film composition suitable for use as a coating material in brain machine interface applications. In 2016, they were a Visiting Scholar at The Ohio State University Wexner Medical Center, where they established multi-disciplinary collaborations to develop biomaterial strategies that target and overcome the physical barrier created by astrocytes and immune cells that prevents functional recovery after a spinal cord injury. Manoj also designed and characterized a cell culture system that aptly mimics the inflammatory in vivo injury environment to promote translational research and evaluated the response of astrocytes and immune cells to biomaterial interventions in vitro using primary cell cultures. Manoj Gottipati, Ph.D. is currently a Senior Scientist at Convelo Therapeutics, Inc., which they began in 2022.

Manoj Gottipati, Ph.D. received their Bachelor of Technology (B.Tech.) in Biotechnology and Biochemical Engineering from the Indian Institute of Technology, Kharagpur in 2010. Manoj then went on to receive their Master of Science (M.S.) in Biomedical Engineering from the University of Alabama at Birmingham in 2012. Finally, they completed their Doctor of Philosophy (Ph.D.) in Biomedical Engineering from the University of Alabama at Birmingham in 2015.